House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3900
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
471
|
An Act requiring immunizations against preventable diseases
|
Support
|
$0.00
|
N/A
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2400
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
House Bill
|
3901
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |